Is Puma Biotechnology Inc (PBYI) Stock at the Top of the Biotechnology Industry?

Wednesday, November 30, 2022 03:09 PM | InvestorsObserver Analysts

Mentioned in this article

Puma Biotechnology Inc (PBYI) is near the top in its industry group according to InvestorsObserver. PBYI gets an overall rating of 78. That means it scores higher than 78 percent of stocks. Puma Biotechnology Inc gets a 94 rank in the Biotechnology industry. Biotechnology is number 57 out of 148 industries.

PBYI has an Overall Score of 78. Find out what this means to you and get the rest of the rankings on PBYI!
See Full PBYI Report

What do These Ratings Mean?

Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 78 means the stock is more attractive than 78 percent of stocks.
These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.

What's Happening With Puma Biotechnology Inc Stock Today?

Puma Biotechnology Inc (PBYI) stock is lower by -2.52% while the S&P 500 is up 2.13% as of 3:08 PM on Wednesday, Nov 30. PBYI is lower by -$0.11 from the previous closing price of $4.56 on volume of 329,536 shares. Over the past year the S&P 500 is down -11.50% while PBYI is up 43.55%. PBYI earned $0.22 a per share in the over the last 12 months, giving it a price-to-earnings ratio of 20.13. Click Here to get the full Stock Report for Puma Biotechnology Inc stock.

Share this article:

Related Articles